Skip to content
10-Q

Quarterly Report

Concert Pharmaceuticals, Inc.

0001367920-22-000075

← back to feed
Filed
Nov 7, 2022 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2022 · Nov 1, 2022 47.94M sh
Shares Diluted Q3 2022 · Sep 30, 2022 49.73M sh
Shares Diluted Q3 2022 · Sep 30, 2022 42.54M sh
Shares Diluted Q3 2022 · Sep 30, 2021 34.09M sh
Shares Diluted Q3 2022 · Sep 30, 2021 33.99M sh
Capex Q3 2022 · Sep 30, 2022 $265K
Capex Q3 2022 · Sep 30, 2021 $239K
Operating Cash Flow Q3 2022 · Sep 30, 2022 −$83.19M
Operating Cash Flow Q3 2022 · Sep 30, 2021 −$28.68M
Cash And Equivalents Q3 2022 · Sep 30, 2022 $95.19M
Cash And Equivalents Q3 2022 · Dec 31, 2021 $141.64M
Cash And Equivalents Q3 2022 · Sep 30, 2021 $103.66M
Stockholders Equity Q3 2022 · Sep 30, 2022 $133.27M
Stockholders Equity Q3 2022 · Jun 30, 2022 $127.79M
Stockholders Equity Q3 2022 · Mar 31, 2022 $76.57M
Stockholders Equity Q3 2022 · Dec 31, 2021 $112.23M
Stockholders Equity Q3 2022 · Sep 30, 2021 $99.16M
Stockholders Equity Q3 2022 · Jun 30, 2021 $122.72M
Stockholders Equity Q3 2022 · Mar 31, 2021 $114.04M
Stockholders Equity Q3 2022 · Dec 31, 2020 $131.16M
Current Liabilities Q3 2022 · Sep 30, 2022 $17.4M
Current Liabilities Q3 2022 · Dec 31, 2021 $16.12M
Total Liabilities Q3 2022 · Sep 30, 2022 $37.86M
Total Liabilities Q3 2022 · Dec 31, 2021 $53.09M
Current Assets Q3 2022 · Sep 30, 2022 $157.2M
Current Assets Q3 2022 · Dec 31, 2021 $150.33M
Total Assets Q3 2022 · Sep 30, 2022 $171.13M
Total Assets Q3 2022 · Dec 31, 2021 $165.32M
Eps Diluted Q3 2022 · Sep 30, 2022 −$0.58
Eps Diluted Q3 2022 · Sep 30, 2022 −$2.13
Eps Diluted Q3 2022 · Sep 30, 2021 −$0.78
Eps Diluted Q3 2022 · Sep 30, 2021 −$1.29
Eps Basic Q3 2022 · Sep 30, 2022 −$0.58
Eps Basic Q3 2022 · Sep 30, 2022 −$2.13
Eps Basic Q3 2022 · Sep 30, 2021 −$0.78
Eps Basic Q3 2022 · Sep 30, 2021 −$1.29
Sga Expense Q3 2022 · Sep 30, 2022 $5.25M
Sga Expense Q3 2022 · Sep 30, 2022 $15.64M
Sga Expense Q3 2022 · Sep 30, 2021 $5.46M
Sga Expense Q3 2022 · Sep 30, 2021 $16.56M
Rd Expense Q3 2022 · Sep 30, 2022 $24.36M
Rd Expense Q3 2022 · Sep 30, 2022 $75.71M
Rd Expense Q3 2022 · Sep 30, 2021 $21.88M
Rd Expense Q3 2022 · Sep 30, 2021 $60.56M
Net Income Q3 2022 · Sep 30, 2022 −$28.9M
Net Income Q3 2022 · Sep 30, 2022 −$90.18M
Net Income Q3 2022 · Jun 30, 2022 −$23.55M
Net Income Q3 2022 · Mar 31, 2022 −$37.73M
Net Income Q3 2022 · Sep 30, 2021 −$26.68M
Net Income Q3 2022 · Sep 30, 2021 −$43.92M
Net Income Q3 2022 · Jun 30, 2021 $5.43M
Net Income Q3 2022 · Mar 31, 2021 −$22.67M
Operating Income Q3 2022 · Sep 30, 2022 −$29.61M
Operating Income Q3 2022 · Sep 30, 2022 −$91.32M
Operating Income Q3 2022 · Sep 30, 2021 −$26.8M
Operating Income Q3 2022 · Sep 30, 2021 −$44.56M
Revenue Q3 2022 · Sep 30, 2022 $8K
Revenue Q3 2022 · Sep 30, 2022 $29K
Revenue Q3 2022 · Sep 30, 2021 $543K
Revenue Q3 2022 · Sep 30, 2021 $32.57M